The STEP-1 trial framework (N=1,961 in semaglutide research) demonstrates how rigorously a drug-drug interaction profile should be established before widespread clinical use [10]
BPC-157, a gastric pentadecapeptide derived from proteolytic enzyme preparations, and TB-500, a synthetic analogue of thymosin beta-4, represent emerging agents with broad biological activity relevant to tissue repair and cytoprotection
GLP-1 drugs may reshape brain's dopamine reward system Beyond weight loss, research is pointing to broader effects on the brain
Decent formula, bad price: Alpha Lion, Nugenix On the flip side of the coin we just described, youll find a few products that have relatively decent formulas, but cost much more than other products that are as good or better
A 12-week medication course addresses none of these underlying drivers in a permanent way
Robert Kushner: Well, GLP-1 and its sister drug GIP were first identified actually in the 1980s